Page 1 of Clinical Trials for ( Alza Corporation AND DE AND USA ) [SPONSOR-COLLABORATORS], 39 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Multicenter Study Comparing the Efficacy and Safety of OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder
Last Updated: June 9, 2011
Condition(s): Attention Deficit Hyperactivity Disorder
2
Completed
A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation.
Last Updated: May 18, 2011
Condition(s): Ejaculation
3
Completed
A Randomized, Open-Label, Single-Dose, Small Study to Evaluate the Safety and Effectiveness of Hydromorphone in Patients With Short Term, Moderate to Severe Postoperative Pain
Last Updated: April 26, 2010
Condition(s): Pain, Postoperative; Orthopedic Procedures; Analgesia
4
Completed
Long-term Safety and Effectiveness of OROS Methylphenidate HCl in Children With Attention Deficit Hyperactivity Disorder
Last Updated: June 13, 2011
Condition(s): Attention Deficit Hyperactivity Disorder
5
Completed
Bioequivalence Between Integrated E-TRANS (Fentanyl) System and Separated (Two-Part) E-TRANS (Fentanyl) System
Last Updated: April 26, 2010
Condition(s): Pain, Postoperative
6
Completed
Study to Investigate the Safety, Tolerability, Absorption, Distribution, Metabolism, and Elimination of RWJ-445380 Administered to Patients With Plaque Psoriasis
Last Updated: February 17, 2011
Condition(s): Chronic Small Plaque Psoriasis
7
Terminated
A Prospective Safety Surveillance Study of Fentanyl Iontophoretic Transdermal System (40 Mcg)
Last Updated: June 8, 2011
Condition(s): Pain, Postoperative
8
Completed
A Study to Evaluate the Safety and Efficacy of OROS® Oxybutynin Chloride for the Treatment of Urge Urinary Incontinence
Last Updated: May 18, 2011
Condition(s): Urinary Incontinence
9
Completed
A Safety and Effectiveness Study of a Single Dose of JNJ-17216498 in Patients With Narcolepsy
Last Updated: October 18, 2010
Condition(s): Narcolepsy
10
Completed
A Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients With Chronic Cancer Pain
Last Updated: April 26, 2010
Condition(s): Analgesics, Opioid; Pain
11
Completed
Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer
Last Updated: May 18, 2011
Condition(s): Pain; Cancer
12
Completed
A Comparison of the Safety and Effectiveness of Two Forms of Patient-controlled Pain Medication Used After Scheduled Abdominal or Pelvic Surgery: The Fentanyl Transdermal System Versus the Morphine Intravenous Pump
Last Updated: May 18, 2011
Condition(s): Pain, Postoperative
13
Completed
Efficacy and Tolerability of DITROPAN XL (Oxybutynin Chloride) Versus DETROL LA (Tolterodine Tartrate) in Treatment of Overactive Bladder
Last Updated: December 7, 2010
Condition(s): Urinary Incontinence
14
Completed
A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients.
Last Updated: April 26, 2010
Condition(s): Pain; Analgesics, Opioid
15
Completed
Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain
Last Updated: April 26, 2010
Condition(s): Pain
16
Completed
A Repeated-Dose Evaluation of a Pain Relieving Drug Use and Safety of OROS Hydromorphone HCI in Patients With Chronic Non-Malignant Pain
Last Updated: April 26, 2010
Condition(s): Pain; Analgesics; Opioid
17
Completed
An Effectiveness, Safety and Quality of Life Measures With Hydromorphone HCL, Dilaudid CR (Controlled Release)
Last Updated: April 26, 2010
Condition(s): Osteoarthritis, Knee; Osteoarthritis, Hip
18
Completed
Safety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release)
Last Updated: April 26, 2010
Condition(s): Pain; Analgesics, Opioid
19
Completed
A Study Comparing the Efficacy and Safety of OROS® Oxybutynin to That of Ditropan® (Immediate-release Oxybutynin) for the Treatment of Patients With Urge or Mixed Urinary Incontinence.
Last Updated: May 18, 2011
Condition(s): Urge Incontinence
20
Completed
An Open-Label Evaluation of the Dose Proportionality of OROS� Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg
Last Updated: April 26, 2010
Condition(s): Analgesia

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Alza+Corporation%2C+DE%2C+USA

Page 1 of Clinical Trials for ( Alza Corporation AND DE AND USA ) [SPONSOR-COLLABORATORS], 39 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About